Table 3. Association between clinical stage and echocardiographic anomalies.
WHO stages | LV dilatation n [%] | Systolic dysfunction n [%] | Pericardial effusion n [%] | Diastolic dysfunction n [%] | Pulmonary hypertension n [%] | LVH n [%] | RV dilatation n [%] |
---|---|---|---|---|---|---|---|
Stage I (n=1) | 0 | 0 | 0 | 0 | 1 [100] | 0 | 1 [100] |
Stage II (n=22) | 0 | 0 | 3 [13.6] | 8 [36] | 0 | 1 [4.5] | 14 [64] |
Stage III (n=44) | 0 | 0 | 6 [13.6] | 12 [27] | 4 [9.3] | 6 [13.6] | 37 [84] |
Stage IV (n=33) | 1 [3] | 1 [3] | 2 [6.0] | 12 [36] | 2 [6.3] | 5 [15.2] | 24 [72] |
Total | 1 [1] | 1 [1] | 11 [11] | 32 [32] | 7 [7] | 12 [12] | 76 [76] |
WHO, World Health Organization; LVH, left ventriclar hypertrophy; RV, right ventricular.